首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies
【24h】

Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies

机译:先前的感染与血液系统恶性肿瘤患者随后的血液感染增加的死亡率相关

获取原文
获取原文并翻译 | 示例
           

摘要

Many patients who are evaluated and treated for sepsis have histories of recent infections. The prognostic implications of surviving an infectious process are not well understood. We undertook this study to determine the clinical impact of prior infections among patients with hematological malignancies, a population at high risk for developing and dying from sepsis. The medical records of 203 patients with hematological malignancies and blood-stream infections admitted over a 3-year period to an urban teaching hospital were retrospectively reviewed. The 30-day mortality after blood-stream infection in these high-risk patients was 24 %. There were 46 patients (23 %) who had inpatient infections in the 90 days prior to the index blood-stream infection. History of recent infection portended worse prognosis from blood-stream infection under multivariable analysis [odds ratio (OR) 2.60, p=0.04, 95 % confidence interval (CI) 1.04-6.47]. There were 86 patients (42 %) who had subsequent infections in the first 90 days after the index blood-stream infection. Patients with subsequent infections had greater mortality during days 91-365 than patients without subsequent infections [hazard ratio (HR) 1.97, p=0.02, 95 % CI 1.13-3.44]. Recent infections prognosticate worse outcomes from subsequent blood-stream infections for this high-risk population. Further research into the clinical and biochemical reasons for this observation may lead to targets for intervention, and, ultimately, improvements in long-term mortality from sepsis.
机译:许多接受败血症评估和治疗的患者都有近期感染的病史。感染过程幸存的预后意义尚不十分清楚。我们进行了这项研究,以确定血液系统恶性肿瘤患者中先前感染对临床的影响,血液恶性肿瘤是发生败血症和死亡的高危人群。回顾性分析了3年来在城市教学医院就诊的203例血液系统恶性肿瘤和血流感染患者的病历。这些高危患者血流感染后30天死亡率为24%。在指数血流感染之前的90天内,有46名患者(23%)发生了住院感染。在多变量分析下,近期感染的历史预示了血流感染的预后较差[几率(OR)2.60,p = 0.04,95%置信区间(CI)1.04-6.47]。在指标血流感染后的前90天内,有86位患者(42%)继发感染。与没有后续感染的患者相比,具有后续感染的患者在91-365天的死亡率更高[危险比(HR)1.97,p = 0.02,95%CI 1.13-3.44]。对于这种高风险人群,最近的感染预示了随后的血液感染可能导致的不良后果。进一步研究这种观察的临床和生化原因可能会导致干预的目标,并最终改善败血症的长期死亡率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号